Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Degos

Showing results (101-110 of 331) with videos related to

Pageof 34
Sort By:
Genetics|June 1, 1975
Formal genetics of the HL-A regionJ Dausset, L Degos, M Fellous, et al.
Seminars in Oncology|June 1, 1985
Drug association including ara-C in myeloid leukemia cell differentiation: in vitro studiesC Chomienne, J P Abita, N Balitrand, et al.
Tissue Antigens|February 1, 1978
HL-A markers in the Vietnamese populationM H Tran, J Hors, M Busson, et al.
Pathologie-Biologie|October 1, 1990
[Immunotherapy of malignant melanoma]B Flageul, J M Miclea, A Bensussan, et al.
Nouvelle Revue Francaise D'Hematologie|November 25, 1978
Principal clinical features and prognosis in chronic lymphocytic leukemiaL Degos, N Feingold, C Bastin, et al.
Presse Medicale (Paris, France : 1983)|February 10, 1990
[Malignant histiocytosis. Remission for more than 5 years]C Lejeunne, L Degos, S Pol, et al.
Leukemia Research|January 1, 1986
1-B-D arabinofuranosyl cytosine and all-trans retinoic acid in combination accelerates and increases monocyte differentiation of myeloid leukemic cellsC Chomienne, N Balitrand, L Degos, et al.
Tissue Antigens|July 1, 1988
Immune response to H-2 class I antigens on platelets. I. Immunogenicity of platelet class I antigensB Frangoulis, D Besluau, M Chopin, et al.
The Journal of Investigative Dermatology|March 1, 1992
TCR gamma delta bearing T lymphocytes infiltrating human primary cutaneous melanomasH Bachelez, B Flageul, L Degos, et al.
Medical and Pediatric Oncology|January 1, 1979
Leukemic phase of malignant histiocytosis (arguments in favour of the histiomonocytic origin of the abnormal cells)J L Harousseau, L Degos, M T Daniel, et al.
Pageof 34

Showing results (101-110 of 331) with videos related to

Sort By:
Pageof 34
Genetics|June 1, 1975
Formal genetics of the HL-A regionJ Dausset, L Degos, M Fellous, et al.
Seminars in Oncology|June 1, 1985
Drug association including ara-C in myeloid leukemia cell differentiation: in vitro studiesC Chomienne, J P Abita, N Balitrand, et al.
Tissue Antigens|February 1, 1978
HL-A markers in the Vietnamese populationM H Tran, J Hors, M Busson, et al.
Pathologie-Biologie|October 1, 1990
[Immunotherapy of malignant melanoma]B Flageul, J M Miclea, A Bensussan, et al.
Nouvelle Revue Francaise D'Hematologie|November 25, 1978
Principal clinical features and prognosis in chronic lymphocytic leukemiaL Degos, N Feingold, C Bastin, et al.
Presse Medicale (Paris, France : 1983)|February 10, 1990
[Malignant histiocytosis. Remission for more than 5 years]C Lejeunne, L Degos, S Pol, et al.
Leukemia Research|January 1, 1986
1-B-D arabinofuranosyl cytosine and all-trans retinoic acid in combination accelerates and increases monocyte differentiation of myeloid leukemic cellsC Chomienne, N Balitrand, L Degos, et al.
Tissue Antigens|July 1, 1988
Immune response to H-2 class I antigens on platelets. I. Immunogenicity of platelet class I antigensB Frangoulis, D Besluau, M Chopin, et al.
The Journal of Investigative Dermatology|March 1, 1992
TCR gamma delta bearing T lymphocytes infiltrating human primary cutaneous melanomasH Bachelez, B Flageul, L Degos, et al.
Medical and Pediatric Oncology|January 1, 1979
Leukemic phase of malignant histiocytosis (arguments in favour of the histiomonocytic origin of the abnormal cells)J L Harousseau, L Degos, M T Daniel, et al.
Pageof 34